The prevalence of cerebral small vessel disease (SVD) is high in Asian populations, particularly in the elderly, a new population-based study reveals. Moreover, SVD is correlated with poorer cognitive function and may be caused by environmental, cultural, and genetic risk factors.
Achieving a systolic blood pressure (SBP) below the currently recommended targets significantly decreases the risk of cardiovascular disease (CVD) and death from any cause, according to a network meta-analysis of 42 randomized trials.
Chronic multimorbidity is highly prevalent among middle-aged adults with cerebral palsy, according to a recent study. In addition, both obesity and poor functional mobility status are independently associated with prevalent multimorbidity.
Results of recent studies presented at the American Psychiatric Association 2017 Annual Meeting showed that electroconvulsive therapy (ECT) is effective for treatment of depression, psychosis and self-harm among patients aged 16–25 years and patients with severe long-lasting depression refractory to treatment.
Patients are more likely to report muscle-related adverse effects (AEs) when they know they are on statins, but not when they have no idea whether they are given statin or placebo in a blinded trial, the ASCOT-LLA* study found, suggesting that clinicians should be aware of potential nocebo effects when prescribing statins.
Long-term use of metformin does not negatively impact cognitive performance, according to a new study, giving clinicians and their patients evidence-based reassurance regarding metformin use as a diabetes prevention pill.
Loneliness can go beyond a sense of social isolation to cause real physical illness. A new study showed loneliness is linked to increased brain inflammation and higher risk of chronic disease and mortality in older adults.